---
schema_version: "secwatch.filing_event.v1"
accession: "0000927653-25-000034"
form_type: "8-K"
ticker: "MCK"
cik: "0000927653"
company_name: "MCKESSON CORP"
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T06:31:07.411443+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# McKesson Q4 revs $90.8B (+19%), adj. EPS $10.12 (+64%); guides FY26 adj. EPS $36.75-37.55; plans Med-Surg spin-off

## Summary
- Q4 consolidated revenues $90.8B (+19% YoY); GAAP diluted EPS $10.01; adjusted diluted EPS $10.12 (+64%).
- Full-year FY25 revenues $359.1B (+16%); adjusted EPS $33.05 (+20%); cash flow from ops $6.1B, FCF $5.2B.
- FY26 adjusted EPS guidance $36.75-$37.55 (11-14% growth); reaffirms long-term adj. EPS growth target 12-14%.
- Announces intention to separate Medical-Surgical Solutions into independent company to unlock shareholder value.
- U.S. Pharmaceutical long-term segment profit growth target raised from 5-7% to 6-8%.

## SEC filing metadata
- accession: 0000927653-25-000034
- form_type: 8-K
- ticker: MCK
- cik: 0000927653
- company_name: MCKESSON CORP
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/927653/000092765325000034/0000927653-25-000034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/927653/000092765325000034/mck-20250508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000927653-25-000034
- JSON: https://secwatch.observer/filing/0000927653-25-000034.json
- Plain text: https://secwatch.observer/filing/0000927653-25-000034.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.